Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

e real underlying value of the company. One announcement can change the share price dramatically. We have created a late stage cancer company with very large potential both to help patients and create profit, particularly since Multikine is not toxic. What is the value of such a product? Once proven to work, probably billions of dollars. Therefore I believe that our value should be much higher today than the current share price, particularly since a cancer drug is not really related to the economic conditions. If we are successful in just some of the projects listed above, the additional value should very quickly be recognized and the current times will be quickly forgotten.

In closing, we believe that the immune system holds the key to treating cancer. We believe that Multikine will be a multi-billion dollar drug because it works with the body to destroy those tumor metastases thought to be responsible for recurrence of the tumor. In our Phase II studies, Multikine when given for only 3 weeks prior to the normal treatment was able to eliminate all tumor in 12% of the patients, reduce the number of tumor cells by an average of 50% in the treatment group and increase long-term overall survival by 33%. This is why you are a shareholder in CEL-SCI! Tell a friend about our great results.

We thank you for your continued support.

Sincerely,

Geert Kersten

Chief Executive Officer

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be s
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... COLORADO SPRINGS, Colo. , March 3, 2015 /PRNewswire/ ... in the development of cannabis-based medicine, today announced two ... preparation for its multiple global product launches, and CEO ... views in the Chicago HR Examiner. In ... C. Waits about leading a company in an ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... PharmaBiotech,s new report "Cardiovascular Drug Delivery - Technologies, ... Drug delivery to the cardiovascular system is ... anatomy and physiology of the vascular system; it supplies ... Drugs can be introduced into the vascular system for ...
(Date:3/3/2015)... YORK , March 3, 2015  Delcath ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces that the ... completed enrollment in 2009, have been submitted for ... clinical study utilized Melphalan Hydrochloride for Injection for ...
Breaking Medicine Technology:CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
... 5, 2011 OncoSec Medical Inc. (OTCBB: ONCS), ... treat solid tumor cancers, announced today the appointment ... will lead the development of the company,s proprietary ... (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... 2011 http://www.reportlinker.com/p0567542/International-Hyaluronic-Acid-Viscosupplementation-Physician-Survey-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic ... specialists were surveyed regarding their perceptions ...
Cached Medicine Technology:OncoSec Medical Appoints Engineering Leader 2OncoSec Medical Appoints Engineering Leader 3International Hyaluronic Acid Viscosupplementation Physician Survey 2011 2International Hyaluronic Acid Viscosupplementation Physician Survey 2011 3International Hyaluronic Acid Viscosupplementation Physician Survey 2011 4International Hyaluronic Acid Viscosupplementation Physician Survey 2011 5International Hyaluronic Acid Viscosupplementation Physician Survey 2011 6International Hyaluronic Acid Viscosupplementation Physician Survey 2011 7International Hyaluronic Acid Viscosupplementation Physician Survey 2011 8
(Date:3/3/2015)... (PRWEB) March 03, 2015 The first ... the National Sleep Foundation. The event brings recognition to ... over. , According to the Centers for ... problems of one form or another. Too little or ... risk of physical illness and depression, and even a ...
(Date:3/3/2015)... Today is International Ear Care Day, ... occasion to applaud and promote the launch of Make ... Organization (WHO) for stemming the threat of noise-induced hearing ... people to practice safe listening when they recreate, be ... sporting events, or engaging in other forms of entertainment. ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The number ... since 1984 to about 15%. This increases to 50% ... (Bushnik T, Cook JL, Yuzpe AA, et al. Estimating ... 27: 738-46). Dr. Jason Hitkari, a reproductive endocrinologist and ... doctor of TCM and clinical director and founder of ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( ... radiology practice, today announced that Arlene Sussman, MD, a ... host a live webinar to explore how telemedicine best ... breast imaging services for women virtually anywhere. Click ... Imaging Service Line” on March 4, 2015 at 1:00 ...
(Date:3/3/2015)... Dallas, Texas (PRWEB) March 03, 2015 ... will serve as chairman of the upcoming Dallas Rhinoplasty ... 2015. The three day symposium, which is attended by ... designed to provide surgeons with detailed information on current ... and revision rhinoplasty surgery . , The ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3
... at Georgetown University Medical Center have discovered that a ... development of mammary cells by activating two critical cancer ... meeting of the American Association for Cancer Research (AACR), ... stem cells and that targeting this gene might provide ...
... Fewer and fewer people are dying after being severely ... his colleagues from Marburg University Hospital report in the ... in Germany sank continuously between 1999 and 2005, decreasing ... Deutsches rzteblatt on the trauma registry of the German ...
... Instrument Generates Real-Time In Vivo Data via Quantitative ... ... VisEn Medical, Inc., a leader,in fluorescence in vivo imaging, today announced ... FMT 2500 is based on VisEn,s,proprietary Fluorescence Molecular Tomography (FMT(TM)) technology,platform, ...
... April 14 PartnerWeekly, a SellingSource, LLC,company, ... billion-a-year cosmetics,industry with the signing of an ... makers of SensiClear, a revolutionary acne,treatment product ... the Janice,Dickinson Modeling Agency. PartnerWeekly is a ...
... community,pharmacy owners looking to pursue the pleasures of ... ApothecaryRx offers successful,independent retail pharmacy owners a smooth ... strength and independence of,the business -- and an ... ApothecaryRx pays fair market value for the ...
... the,nation,s 78 million baby boomers begin reaching age 65 ... that is too small and woefully unprepared to,meet their ... Institute of,Medicine. The report calls for bold initiatives starting ... specialists -- in the basics of,geriatric care and to ...
Cached Medicine News:Health News:Georgetown researchers find stem cell marker controls 2 key cancer pathways 2Health News:VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System 2Health News:PartnerWeekly and SensiClear(TM) Sign Online Marketing Pact 2Health News:ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors 2Health News:ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors 3Health News:ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors 4Health News:Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis 2
... Model V-1000 is a new addition to the ... This high performance pump can achieve an ultimate ... of 64 L/min. Applications For ... concentrators Distillation applications from lab size ...
... is a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with up to ... for instruments including vacuum ovens, concentrators, gel dryers, ... PEEK head resistant to chemicals and heat ...
... High Vacuum pumps deliver critical performance ... gas ballast control optimizes pump performance to ... glass allows for convenient checking of proper ... series of pumps is designed to work ...
... critical performance for all vacuum requirements. A ... performance to suit all applications. The large, ... of proper oil levels at a glance. ... to work with all Thermo Savant SpeedVac ...
Medicine Products: